Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.
Dr. Michael Fulks, Consulting Medical Director, details a new study showcasing the increase in mortality rates from drug and alcohol… Read More
Tags: Alcohol usage, Drug usage, Life expectancy, Life Insurance, Mortality, Overdose
Michael Fulks, MD, comments on recent research in the Journal of the American College of Cardiology. Dr. Fulks reviews the… Read More
Tags: Coronary heart disease, HDL, Life Insurance, Mortality, Research
In conjunction with industry partners APPS, ExamOne, and IMS Paramed, we recently collaborated on an effort to analyze and understand… Read More
Tags: Diabetes, Hypertension, Life Insurance, Mortality, Underwriting
Dr. Michael Fulks comments on drugs targeted for weight loss in patients with type 2 diabetes. Last year we blogged… Read More
Tags: Life Insurance, Metabolism, Mortality, Weight loss
Consulting Medical Director Michael Fulks discusses new data from the CDC for evaluating drug use, potential overdose risk, and life… Read More
Tags: Drug usage, Life Insurance, Mortality, Overdose
Mortality has steadily improved in the U.S. until recently, when COVID-19 and fentanyl-related deaths increased. However, the disparity in mortality… Read More
Tags: Life expectancy, Life Insurance, Mortality
In conjunction with industry partners APPS, ExamOne and IMS Paramed, we recently collaborated on an effort to analyze and understand… Read More
Tags: Cigarettes, Insurance, Mortality, Nicotine, Risk
Consulting medical director Michael Fulks, MD, comments on recent changes to the leading causes of death because of COVID-19, drugs,… Read More
Tags: Cancer, Covid 19, Drug overdose, Life Insurance, Mortality
The conclusions of the Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference were recently published.1 This expert panel started with… Read More
Tags: eGFR, Kidney, Life Insurance, Mortality, Risk
It’s a simple concept: the more people you can label as having a condition for which you provide support (as… Read More
Tags: Diabetes, Insurance, Mortality, Study, Underwriting
If you would like to sign up to receive email updates from the Insurer team, please click here.